The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Self-citationHarper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Self-citationA Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Self-citationVilla, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Self-citationComparative analysis of two rates
Miettinen, O., & Nurminen, M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,110
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Clifford, G. M., Rana, R. K., Franceschi, S., Smith, J. S., Gough, G., & Pimenta, J. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0812 · Cited by 533
External Genital Warts: Diagnosis, Treatment, and Prevention
Wiley, D. J., Douglas, J., Beutner, K., Cox, T., Fife, K., Moscicki, A., & Fukumoto, L. (2002) · Clinical Infectious Diseases · doi:10.1086/342109 · Cited by 354
Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
McMahon, B. J., Bruden, D. L., Petersen, K. M., Bulkow, L. R., Parkinson, A. J., Nainan, O., Khristova, M., Zanis, C., Peters, H., & Margolis, H. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00008 · Cited by 315
Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N., & Esser, M. T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.108-115.2003 · Cited by 276
Self-citationPrevalence and determinants of HPV infection among Colombian women with normal cytology
the HPV Study Group HPV Study, Molano, M., Posso, H., Weiderpass, E., van den Brule, A. J. C., Ronderos, M., Franceschi, S., Meijer, C. J. L. M., Arslan, A., & Munoz, N. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600442 · Cited by 263
Christensen, N. D., Dillner, J., Eklund, C., Carter, J. J., Wipf, G. C., Reed, C. A., Cladel, N. M., & Galloway, D. A. (1996) · Virology · doi:10.1006/viro.1996.0466 · Cited by 255
Dias, D., Van Doren, J., Schlottmann, S., Kelly, S., Puchalski, D., Ruiz, W., Boerckel, P., Kessler, J., Antonello, J. M., Green, T., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.8.959-969.2005 · Cited by 241
Self-citationPeto, J., Gilham, C., Deacon, J., Taylor, C., Evans, C., Binns, W., Haywood, M., Elanko, N., Coleman, D., Yule, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602049 · Cited by 238
Maw, R. D., Reitano, M., & Roy, M. (1998) · International Journal of STD & AIDS · doi:10.1258/0956462981921143 · Cited by 176
Whittle, H., Jaffar, S. S., Wansbrough, M., Mendy, M., Dumpis, U., Collinson, A., & Hall, A. (2002) · BMJ · doi:10.1136/bmj.325.7364.569 · Cited by 156
Hepatitis B vaccination in infancy in The Gambia: protection
Viviani, S., Jack, A., Hall, A. J., Maine, N., Mendy, M. E., Montesano, R., & Whittle, H. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00178-4 · Cited by 152
Hausen, H. Z. (2001) · Oncogene · doi:10.1038/sj.onc.1204958 · Cited by 151
The health care costs of cervical human papillomavirus–related disease
Insinga, R. P., Glass, A. G., & Rush, B. B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.042 · Cited by 145
Hofmann, K. J., Cook, J. C., Joyce, J. G., et al. (1995) · Virology · doi:10.1006/viro.1995.1283 · Cited by 134
Christensen, N. D., Reed, C. A., Cladel, N. M., Hall, K., & Leiserowitz, G. S. (1996) · Virology · doi:10.1006/viro.1996.0554 · Cited by 117
Emeny, R. T., Wheeler, C. M., Jansen, K. U., Hunt, W. C., Fu, T., Smith, J. F., MacMullen, S. A., Esser, M. T., & Paliard, X. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7832-7842.2002 · Cited by 101
Self-citationA phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
Ault, K. A., Giuliano, A. R., Edwards, R. P., Tamms, G. M., Kim, L.-L., Smith, J. F., Jansen, K. U., Allende, M. C., Taddeo, F. J., Skulsky, D., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.020 · Cited by 99
Self-citationEarly assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
Brown, D. R., Fife, K. H., Wheeler, C. M., Koutsky, L. A., Lupinacci, L. C., Railkar, R. A., Suhr, G., Barr, E., DiCELLO, A. C., Li, W., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.059 · Cited by 88
Self-citationBrown, D. R., Bryan, J. T., Schroeder, J. M., Robinson, T. S., Fife, K. H., Wheeler, C. M., Barr, E., Smith, P. R., Chiacchierini, L. M., DiCELLO, A. C., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323645 · Cited by 79
Self-citationPoland, G. A., Jacobson, R. M., Koutsky, L. A., Tamms, G. M., Railkar, R. A., Smith, J. F., Bryan, J. T., Cavanaugh, P. F., Jansen, K. U., & Barr, E. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.5.601 · Cited by 60
Self-citationPalker, T. J., Monteiro, J. M., Martin, M. M., Kakareka, C., Smith, J. F., Cook, J. C., Joyce, J. G., & Jansen, K. U. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00093-7 · Cited by 58
Self-citation
Cited by
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
Predictors of HPV vaccine acceptability: A theory-informed, systematic review
Brewer, N. T., & Fazekas, K. I. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.05.013 · Cited by 862
Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Paavonen, J., Iversen, O.-E., Olsson, S.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 806
Self-citationHildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007) · JAMA · doi:10.1001/jama.298.7.743 · Cited by 666
Arbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009069.pub3 · Cited by 621
Metadata
- Authors
- Villa, L. L., Ault, K. A., Giuliano, A. R., Costa, R. L. R., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A., Harper, D. M., Koutsky, L. A., Kurman, R. J., Lehtinen, M., Malm, C., Olsson, S.-E., Ronnett, B. M., Skjeldestad, F. E., Steinwall, M., Stoler, M. H., Wheeler, C. M., Taddeo, F. J., Yu, J., Lupinacci, L., Railkar, R., Marchese, R., Esser, M. T., Bryan, J., Jansen, K. U., Sings, H. L., Tamms, G. M., Saah, A. J., & Barr, E.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 24
- Issue
- 27-28
- Pages
- 5571-5583
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2117699409
- Cited by
- 469
- References
- 29
- FWCI
- 45.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.